1. Translational mechanisms at work in the cohesinopathies.
- Author
-
Gerton JL
- Subjects
- Acetyltransferases genetics, Acetyltransferases metabolism, Cell Cycle Proteins genetics, Cell Nucleolus metabolism, Chondroitin Sulfate Proteoglycans metabolism, Chromosomal Proteins, Non-Histone genetics, Chromosome Segregation, Chromosomes metabolism, Craniofacial Abnormalities etiology, Craniofacial Abnormalities genetics, De Lange Syndrome etiology, De Lange Syndrome genetics, Ectromelia etiology, Ectromelia genetics, Humans, Hypertelorism etiology, Hypertelorism genetics, Mutation, Ribosomes metabolism, Cohesins, Cell Cycle Proteins metabolism, Chromosomal Proteins, Non-Histone metabolism, Craniofacial Abnormalities metabolism, De Lange Syndrome metabolism, Ectromelia metabolism, Hypertelorism metabolism, Protein Biosynthesis physiology
- Abstract
Chromosome cohesion, mediated by the cohesin complex, is essential for the process of chromosome segregation. Mutations in cohesin and its regulators are associated with a group of human diseases known as the cohesinopathies. These diseases are characterized by defects in head, face, limb, and heart development, mental retardation, and poor growth. The developmental features of the diseases are not well explained by defects in chromosome segregation, but instead are consistent with changes in gene expression during embryogenesis. Thus a central question to understanding the cohesinopathies is how mutations in cohesin lead to changes in gene expression. One of the prevailing models is that cohesin binding to promoters and enhancers directly regulates transcription. I propose that in addition cohesin may influence gene expression via translational mechanisms. If true, cohesinopathies may be related in etiology to another group of human diseases known as ribosomopathies, diseases caused by defects in ribosome biogenesis. By considering this possibility we can more fully evaluate causes and treatments for the cohesinopathies.
- Published
- 2012
- Full Text
- View/download PDF